As of the latest SEC filings, Corvus Pharmaceuticals, Inc. (CRVS) is held by 168 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $34,226,972.78 in market value, representing a significant portion of its portfolio.
Funds holding Corvus Pharmaceuticals, Inc. (CRVS)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CRVS
- CIK:
- 0001626971
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $34,226,972.78 | 2,339,506 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.42% | $30,969,632.54 | 2,116,858 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $22,938,698.86 | 1,567,922 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $12,003,359.06 | 820,462 | Mar 31, 2026 | May 28, 2026 |
|
HRSMX
Hood River Small-Cap Growth Fund
|
MF | Independent / Boutique | 0.21% | $10,886,095.22 | 744,094 | Mar 31, 2026 | May 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.10% | $10,608,198.37 | 725,099 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.08% | $10,566,985.66 | 722,282 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.03% | $9,677,305.96 | 637,084 | Apr 30, 2026 | Jun 26, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.10% | $8,303,988.00 | 567,600 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 0.51% | $8,046,500.00 | 550,000 | Mar 31, 2026 | May 29, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.06% | $7,690,683.77 | 525,679 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $6,929,213.50 | 379,475 | Feb 28, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.09% | $6,924,759.38 | 473,326 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.03% | $5,178,864.68 | 283,618 | Feb 28, 2026 | Apr 28, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $3,063,845.40 | 167,790 | Feb 28, 2026 | Apr 28, 2026 |
|
FFGRX
Emerald Growth Fund
|
MF | Independent / Boutique | 0.20% | $2,864,575.77 | 188,583 | Apr 30, 2026 | Jun 22, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.11% | $2,653,328.44 | 174,676 | Apr 30, 2026 | Jun 25, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $2,472,385.74 | 135,399 | Feb 28, 2026 | Apr 24, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.20% | $2,373,220.08 | 162,216 | Mar 31, 2026 | May 28, 2026 |
|
VFMO
VANGUARD U.S. MOMENTUM FACTOR ETF
|
ETF | Vanguard | 0.16% | $2,240,885.46 | 122,721 | Feb 28, 2026 | Apr 28, 2026 |
|
IHSVX
THE HARTFORD SMALL COMPANY FUND
|
MF | Independent / Boutique | 0.34% | $2,239,537.65 | 147,435 | Apr 30, 2026 | Jun 25, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.03% | $2,147,850.81 | 141,399 | Apr 30, 2026 | Jun 25, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.03% | $2,016,342.24 | 110,424 | Feb 27, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,967,661.08 | 107,758 | Feb 28, 2026 | Apr 24, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.35% | $1,841,043.19 | 121,201 | Apr 30, 2026 | Jun 29, 2026 |
Advertisement (320x50)